Evidence map›Paper›PMID 39081246›Full record

ArticleJournal of microbiology and biotechnology2024

A Novel Truncated CHAP Modular Endolysin, CHAP

Yoon-Jung Choi, Shukho Kim, Ram Hari Dahal, Jungmin Kim

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of microbiology and biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yoon-Jung ChoiDepartment of Microbiology, School of Medicine, Kyungpook National University, Daegu 41566, Republic of Korea.
Shukho KimDepartment of Microbiology, School of Medicine, Kyungpook National University, Daegu 41566, Republic of Korea.
Ram Hari DahalDepartment of Microbiology, School of Medicine, Kyungpook National University, Daegu 41566, Republic of Korea.
Jungmin KimDepartment of Microbiology, School of Medicine, Kyungpook National University, Daegu 41566, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Development of novel antibacterial agents is imperative due to the increasing threat of antibiotic-resistant pathogens. This study aimed to develop the enhanced antibacterial activity and in-vivo efficacy of a novel truncated endolysin, CHAP

Indexed as

Acinetobacter baumanniiAnti-Bacterial AgentsClostridioides difficileDisease Models, AnimalEndopeptidasesMicrobial Sensitivity TestsStaphylococcus aureusAcinetobacter InfectionsAnimalsDrug Resistance, Multiple, BacterialEscherichia coliFemaleHydrogen-Ion ConcentrationMiceMice, Inbred BALB CStaphylococcal InfectionsAnti-Bacterial AgentsendolysinEndopeptidasesAcinetobacter baumanniideletion mutantsEndolysinresistanceStaphylococcus aureus

Identifiers

PMID39081246
PMCPMC11380504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.